VOYA Investment Management
NGNE icon

VOYA Investment Management’s Neurogene NGNE Stock Holding History

VOYA Investment Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-686
Closed -$26K – 2851
2022
Q1 		$26K Hold
686
– – ﹤0.01% 2639
2021
Q4 		$66K Sell
686
-30
-4% -$3.65K ﹤0.01% 2725
2021
Q3 		$103K Hold
716
– – ﹤0.01% 2729
2021
Q2 		$132K Sell
716
-2
-0.3% -$442 ﹤0.01% 2710
2021
Q1 		$177K Sell
718
-19
-3% -$4.86K ﹤0.01% 2571
2020
Q4 		$208K Sell
737
-196
-21% -$47.9K ﹤0.01% 2394
2020
Q3 		$224K Buy
933
+418
+81% +$101K ﹤0.01% 2105
2020
Q2 		$171K Buy
+515
New +$134K ﹤0.01% 2205

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VOYA Investment Management's NGNE Position: Q2 2022 in Review

VOYA Investment Management sold out of Neurogene (NGNE) in Q2 2022, closing a stake of 686 shares — an estimated $26K sold.

VOYA Investment Management first reported a position in NGNE in Q2 2020 and held it in 8 quarters. The position peaked at $224K in Q3 2020. 63 funds tracked by Wall St. Rank hold NGNE as of Q2 2022.

  • VOYA Investment Management reported no remaining Neurogene position as of Q2 2022 after selling out during the quarter.
  • VOYA Investment Management sold 686 Neurogene shares in Q2 2022, an estimated $26K.
  • VOYA Investment Management first reported a position in Neurogene in Q2 2020 and held it in 8 quarters.
  • VOYA Investment Management's Neurogene position peaked at $224K in Q3 2020.
  • 63 funds tracked by Wall St. Rank held Neurogene as of Q2 2022.

Based on VOYA Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.